Study finds gene expression differences in male and female athletes with ACL injuries

Findings may be 'tip of the iceberg' in determining the role of genetics in ACL structure

Female athletes are two-to-eight times more likely to suffer an anterior cruciate ligament (ACL) injury than males. And while there have been reports about possible anatomic, hormonal and neuromuscular factors that may place females at greater risk for these injuries, little research has looked specifically at the role of genetics.

For the first time, a new study, presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), identified varied female-to-male expression of several genes leading to proteins maintaining ligament structure.

In "Gene Expression Differences in Young Male and Female Ruptured Anterior Cruciate Ligaments," researchers obtained a biopsy of normally discarded ruptured ACL tissue during surgery from seven male and seven female young athlete patients. Biopsies were then divided into groups for microscopic (histological) and gene microarray analysis. Thirty-two significantly differentially expressed genes were isolated from male and female tissue, of which 14 were not linked to either X or Y chromosome. The 14 genes were then grouped according to skeletal muscular development, function and cellular growth. In females, compared to males, the microarray analysis showed altered responses in signaling pathways that regulate cartilage and tissue growth.

The study authors believe the findings represent "the tip of the iceberg" in terms of determining the role of genetics in ACL structure and tendency toward increased ligament injury in female compared to male athletes.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Assessing recurrence risk with ctDNA-based MRD detection in NSCLC patients